Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00489320 · ClinicalTrials.gov registry record
An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting (DEScover Registry).
A clinical trial, sponsored by Cordis US.
- Completed
- Registry status
- 7,759
- Enrollment target
NCT00489320: Completed study, sponsored by Cordis US.
NCT00489320 is a clinical trial that has completed, run by Cordis US. The registered enrollment target is 7,759 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00489320 has completed, sponsored by Cordis US.
- COMPLETED
- Registry status
- 7,759 participants
- Enrollment target
Study Summary
The DEScover Registry is designed to observe the results of using Drug Eluting Stents (DES) in patients in a real-world setting. The stents being observed are not investigational, that is, they have been approved for use in the general population.
Interventions
- DEVICE Cypher Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,759 participants |
| Start Date | 2004-12 |
| Est. Completion | 2006-07 |
What the finished NCT00489320 record still lists
NCT00489320 is an observational study that tracks outcomes without assigning an intervention. Its 7,759 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Cypher Stent is the first listed.
NCT00489320 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00489320 about?
NCT00489320 is a clinical study titled "An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting (DEScover Registry).". The DEScover Registry is designed to observe the results of using Drug Eluting Stents (DES) in patients in a real-world setting. The stents being observed are not investigational, that is, they have been approved for use in the general population.
What is the current status of trial NCT00489320?
This trial is currently completed. The enrollment target is 7,759 participants. The study started on 2004-12. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00489320?
The interventions under investigation include: Cypher Stent (DEVICE).
Who is sponsoring clinical trial NCT00489320?
This trial is sponsored by Cordis US, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06560398 · 7,649 participants · NA
Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)
- NCT03848312 · 7,600 participants · Phase 3
Preventing Alzheimer's With Cognitive Training
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- NCT00898638 · 8,000 participants
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia